Annual CFO
-$6.32 M
-$645.40 K-11.38%
30 June 2024
Summary:
NanoViricides annual cash flow from operations is currently -$6.32 million, with the most recent change of -$645.40 thousand (-11.38%) on 30 June 2024. During the last 3 years, it has risen by +$1.90 million (+23.11%).NNVC Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$2.59 M
-$1.11 M-75.18%
01 September 2024
Summary:
NanoViricides quarterly cash flow from operations is currently -$2.59 million, with the most recent change of -$1.11 million (-75.18%) on 01 September 2024. Over the past year, it has dropped by -$1.42 million (-121.46%). NNVC quarterly CFO is now -2693.22% below its all-time high of -$92.90 thousand, reached on 31 December 2009.NNVC Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$7.74 M
-$1.42 M-22.54%
01 September 2024
Summary:
NanoViricides TTM cash flow from operations is currently -$7.74 million, with the most recent change of -$1.42 million (-22.54%) on 01 September 2024. Over the past year, it has dropped by -$1.93 million (-33.22%). NNVC TTM CFO is now -896.74% below its all-time high of -$776.40 thousand, reached on 30 September 2006.NNVC TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NNVC Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -11.4% | -121.5% | -33.2% |
| 3 y3 years | +23.1% | -258.3% | -15.5% |
| 5 y5 years | +7.2% | -81.0% | -6.4% |
NNVC Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -11.4% | +23.1% | -258.3% | at low | -41.1% | at low |
| 5 y | 5 years | -11.4% | +23.1% | -258.3% | at low | -41.1% | +10.6% |
| alltime | all time | <-9999.0% | +23.1% | -2693.2% | +26.3% | -896.7% | +12.1% |
NanoViricides Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.59 M(+75.2%) | -$7.74 M(+22.5%) |
| June 2024 | -$6.32 M(+11.4%) | -$1.48 M(-23.8%) | -$6.32 M(-0.3%) |
| Mar 2024 | - | -$1.94 M(+13.1%) | -$6.33 M(+3.4%) |
| Dec 2023 | - | -$1.72 M(+46.7%) | -$6.13 M(+5.5%) |
| Sept 2023 | - | -$1.17 M(-21.8%) | -$5.81 M(+2.4%) |
| June 2023 | -$5.67 M(-3.8%) | -$1.50 M(-13.8%) | -$5.67 M(+1.8%) |
| Mar 2023 | - | -$1.74 M(+24.1%) | -$5.57 M(+1.5%) |
| Dec 2022 | - | -$1.40 M(+35.6%) | -$5.49 M(-11.5%) |
| Sept 2022 | - | -$1.03 M(-26.1%) | -$6.20 M(+5.2%) |
| June 2022 | -$5.89 M(-28.3%) | -$1.40 M(-15.6%) | -$5.89 M(-12.3%) |
| Mar 2022 | - | -$1.66 M(-21.7%) | -$6.72 M(+3.4%) |
| Dec 2021 | - | -$2.11 M(+191.9%) | -$6.50 M(-3.0%) |
| Sept 2021 | - | -$724.20 K(-67.5%) | -$6.70 M(-18.4%) |
| June 2021 | -$8.21 M(+23.2%) | -$2.23 M(+55.3%) | -$8.21 M(+6.7%) |
| Mar 2021 | - | -$1.43 M(-38.0%) | -$7.69 M(-11.1%) |
| Dec 2020 | - | -$2.32 M(+3.6%) | -$8.66 M(+15.9%) |
| Sept 2020 | - | -$2.24 M(+30.9%) | -$7.47 M(+12.0%) |
| June 2020 | -$6.67 M(-2.0%) | -$1.71 M(-28.7%) | -$6.67 M(+0.5%) |
| Mar 2020 | - | -$2.40 M(+112.8%) | -$6.63 M(+6.2%) |
| Dec 2019 | - | -$1.13 M(-21.5%) | -$6.24 M(-14.2%) |
| Sept 2019 | - | -$1.43 M(-14.2%) | -$7.27 M(+6.9%) |
| June 2019 | -$6.80 M(-12.5%) | -$1.67 M(-16.8%) | -$6.80 M(-21.4%) |
| Mar 2019 | - | -$2.01 M(-6.9%) | -$8.65 M(+9.0%) |
| Dec 2018 | - | -$2.16 M(+124.3%) | -$7.94 M(+10.5%) |
| Sept 2018 | - | -$962.20 K(-72.7%) | -$7.18 M(-7.6%) |
| June 2018 | -$7.78 M(-1.5%) | -$3.52 M(+171.6%) | -$7.78 M(+47.7%) |
| Mar 2018 | - | -$1.30 M(-7.7%) | -$5.27 M(-12.6%) |
| Dec 2017 | - | -$1.40 M(-9.8%) | -$6.02 M(-16.7%) |
| Sept 2017 | - | -$1.56 M(+54.2%) | -$7.23 M(-8.5%) |
| June 2017 | -$7.90 M(+15.6%) | -$1.01 M(-50.8%) | -$7.90 M(-4.5%) |
| Mar 2017 | - | -$2.05 M(-21.4%) | -$8.27 M(-6.0%) |
| Dec 2016 | - | -$2.61 M(+17.4%) | -$8.80 M(+18.9%) |
| Sept 2016 | - | -$2.22 M(+61.0%) | -$7.40 M(+8.4%) |
| June 2016 | -$6.83 M(+9.9%) | -$1.38 M(-46.4%) | -$6.83 M(+1.9%) |
| Mar 2016 | - | -$2.58 M(+112.8%) | -$6.70 M(+7.9%) |
| Dec 2015 | - | -$1.21 M(-26.7%) | -$6.21 M(+0.7%) |
| Sept 2015 | - | -$1.65 M(+31.7%) | -$6.17 M(-0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2015 | -$6.21 M(-1.9%) | -$1.26 M(-39.9%) | -$6.21 M(+5.1%) |
| Mar 2015 | - | -$2.09 M(+78.2%) | -$5.91 M(+4.0%) |
| Dec 2014 | - | -$1.17 M(-30.9%) | -$5.68 M(-15.2%) |
| Sept 2014 | - | -$1.70 M(+77.5%) | -$6.71 M(+5.9%) |
| June 2014 | -$6.33 M(+9.2%) | -$955.60 K(-48.6%) | -$6.33 M(-6.2%) |
| Mar 2014 | - | -$1.86 M(-15.2%) | -$6.75 M(+2.3%) |
| Dec 2013 | - | -$2.19 M(+65.6%) | -$6.60 M(+14.2%) |
| Sept 2013 | - | -$1.32 M(-3.5%) | -$5.78 M(-0.4%) |
| June 2013 | -$5.80 M(+37.5%) | -$1.37 M(-19.7%) | -$5.80 M(+8.9%) |
| Mar 2013 | - | -$1.71 M(+24.5%) | -$5.32 M(+5.7%) |
| Dec 2012 | - | -$1.37 M(+2.0%) | -$5.03 M(+3.0%) |
| Sept 2012 | - | -$1.35 M(+50.1%) | -$4.89 M(+15.9%) |
| June 2012 | -$4.22 M(-6.4%) | -$896.50 K(-36.8%) | -$4.22 M(+1.3%) |
| Mar 2012 | - | -$1.42 M(+15.7%) | -$4.16 M(+5.1%) |
| Dec 2011 | - | -$1.23 M(+81.3%) | -$3.96 M(+6.1%) |
| Sept 2011 | - | -$676.30 K(-19.6%) | -$3.74 M(-17.1%) |
| June 2011 | -$4.51 M(+120.2%) | -$841.10 K(-31.0%) | -$4.51 M(+13.2%) |
| Mar 2011 | - | -$1.22 M(+21.9%) | -$3.98 M(+5.2%) |
| Dec 2010 | - | -$999.50 K(-31.0%) | -$3.78 M(+31.5%) |
| Sept 2010 | - | -$1.45 M(+358.7%) | -$2.88 M(+40.5%) |
| June 2010 | -$2.05 M(-23.7%) | -$315.80 K(-69.0%) | -$2.05 M(-5.3%) |
| Mar 2010 | - | -$1.02 M(+997.8%) | -$2.16 M(+15.1%) |
| Dec 2009 | - | -$92.90 K(-85.0%) | -$1.88 M(-29.4%) |
| Sept 2009 | - | -$619.00 K(+44.0%) | -$2.66 M(-0.8%) |
| June 2009 | -$2.68 M(+5.2%) | -$429.80 K(-41.6%) | -$2.68 M(+3.7%) |
| Mar 2009 | - | -$736.50 K(-15.8%) | -$2.59 M(+2.1%) |
| Dec 2008 | - | -$875.20 K(+36.6%) | -$2.53 M(-2.1%) |
| Sept 2008 | - | -$640.50 K(+92.1%) | -$2.59 M(+1.4%) |
| June 2008 | -$2.55 M(+9.3%) | -$333.50 K(-51.2%) | -$2.55 M(+0.8%) |
| Mar 2008 | - | -$683.50 K(-26.4%) | -$2.53 M(-5.4%) |
| Dec 2007 | - | -$929.10 K(+53.7%) | -$2.67 M(+23.7%) |
| Sept 2007 | - | -$604.30 K(+93.3%) | -$2.16 M(-7.4%) |
| June 2007 | -$2.33 M(+27.9%) | -$312.60 K(-62.2%) | -$2.33 M(+15.5%) |
| Mar 2007 | - | -$827.30 K(+98.5%) | -$2.02 M(+69.3%) |
| Dec 2006 | - | -$416.80 K(-46.3%) | -$1.19 M(+53.7%) |
| Sept 2006 | - | -$776.40 K | -$776.40 K |
| June 2006 | -$1.82 M(<-9900.0%) | - | - |
| June 2005 | $0.00 | - | - |
FAQ
- What is NanoViricides annual cash flow from operations?
- What is the all time high annual CFO for NanoViricides?
- What is NanoViricides annual CFO year-on-year change?
- What is NanoViricides quarterly cash flow from operations?
- What is the all time high quarterly CFO for NanoViricides?
- What is NanoViricides quarterly CFO year-on-year change?
- What is NanoViricides TTM cash flow from operations?
- What is the all time high TTM CFO for NanoViricides?
- What is NanoViricides TTM CFO year-on-year change?
What is NanoViricides annual cash flow from operations?
The current annual CFO of NNVC is -$6.32 M
What is the all time high annual CFO for NanoViricides?
NanoViricides all-time high annual cash flow from operations is $0.00
What is NanoViricides annual CFO year-on-year change?
Over the past year, NNVC annual cash flow from operations has changed by -$645.40 K (-11.38%)
What is NanoViricides quarterly cash flow from operations?
The current quarterly CFO of NNVC is -$2.59 M
What is the all time high quarterly CFO for NanoViricides?
NanoViricides all-time high quarterly cash flow from operations is -$92.90 K
What is NanoViricides quarterly CFO year-on-year change?
Over the past year, NNVC quarterly cash flow from operations has changed by -$1.42 M (-121.46%)
What is NanoViricides TTM cash flow from operations?
The current TTM CFO of NNVC is -$7.74 M
What is the all time high TTM CFO for NanoViricides?
NanoViricides all-time high TTM cash flow from operations is -$776.40 K
What is NanoViricides TTM CFO year-on-year change?
Over the past year, NNVC TTM cash flow from operations has changed by -$1.93 M (-33.22%)